NCT00145691View on ClinicalTrials.gov

The Effect of Oxcarbazepine in the Treatment of Agitation / Aggression in Dementia (OBAD)

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

October 31, 2006

Conditions
Agitation Aggression in Dementia
Interventions
DRUG

Oxcarbazepine

Trial Locations (1)

2840

Sykehuset Innlandet HF, Reinsvoll

All Listed Sponsors
lead

Sykehuset Innlandet HF

OTHER

NCT00145691 - The Effect of Oxcarbazepine in the Treatment of Agitation / Aggression in Dementia (OBAD) | Biotech Hunter | Biotech Hunter